Bone has a capacity to regenerate after suffering partial damage. However, this regeneration becomes difficult when a serious break or tumor lesion occurs and the loss of tissue is substantial. Today, these cases are treated with various grafts with a number of disadvantages, such as limitations with donors. There is a demonstrated clinical need for alternatives of autologous fresh bone graft with excellent biological performance. Smart nanoengineered materials allow novel therapeutic modalities such as improved specific cell targeting by means of nanoparticle-based drugs, resulting in a decreased side effects for patients. Recently, nanomedicine has taken issue for drug delivery, gene delivery and regenerative medicine [1] [2] [3] [4] . Other advances are being made in sophisticated biomaterials for use in less invasive surgical implantations, leading to shorter recovery times and decreased risk of postoperative infections or other complications. Such innovations will improve the quality of life, extend life expectancies and should reduce the overall cost of healthcare.
Biomaterials also play central roles in modern strategies in regenerative medicine and tissue engineering as designable biophysical and biochemical milieus that direct cellular behavior and function. Tissue engineering is an inter disciplinary field that has attempted to implement a variety of processing methods for synthetic and natural polymers to fabricate tissue and organ regeneration scaffolds. Such materials should provide provisional 3D supports to interact with cells in ways that control their function by guiding the spatially and temporally complex multicellular processes of tissue formation and regeneration [5] [6] [7] [8] [9] [10] [11] [12] . The guidance provided by biomaterials may facilitate restoration of structure and function of damaged or dysfunctional tissues.
Several biomimicking medical devices for regenerative medicine have been inspired by the intricate fibrillar architecture of natural extracellular matrix (ECM) components [13] . Such matrices have already shown remarkable success in tissue-engineering applications [8, 14] , examples of which include reconstruction of a dog urinary bladder [13] and the regeneration after brain injury in a mouse stroke model [15] . However, it has been established that inert ECM mimetic scaffolds are not efficient at generating durable tissue repair. Therefore, there is a need for materials that ensure the sustained release of active compounds. To this end, recent advances in nanotechnology have led to various engineered ECM analogs and biomaterials incorporated with active compounds (drugs, genes or growth factors) within the form of layer-by-layer (LbL) coatings built-up from oppositely charged macromolecules [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] .
As considerable effort is currently devoted to the design of nanostructured functional materials, ultrathin polyelectrolyte multilayer (PEM) coatings built-up from oppositely charged macromolecules constitute promising candidates, particularly in the field of biomaterials [16, 17, 31, 33] . These supramolecular nanoarchitectures can not only specifically control cell activation, but Implants triggering rapid, robust and durable tissue regeneration are needed to shorten recovery times and decrease risks of postoperative complications for patients. Here, we describe active living collagen implants with highly promising bone regenerative properties. Bioactivity of the implants is obtained through the protective and stabilizing layer-by-layer immobilization of a protein growth factor in association with a polysaccharide (chitosan), within the form of nanocontainers decorating the collagen nanofibers. All components of the implants are US FDA approved. From both in vitro and in vivo evaluations, the sophisticated strategy described here should enhance, at a reduced cost, the safety and efficacy of the therapeutic implants in terms of large bone defects repair compared with current simplistic approaches based on the soaking of the implants with protein growth factor. KEYWORDS: n bone morphogenetic protein 2 n bone regeneration n collagen implant n drug delivery n layer-by-layer deposition n regenerative nanomedicine [19, [21] [22] [23] [24] [25] [26] [27] 30, 33] .
Sandy
In orthopaedic surgery, Geistlich Bio-Gide™ collagen membranes are currently used for guided bone regeneration and guided tissue regeneration. The success of this membrane is based on the natural bilayer structure, which contributes to excellent soft-tissue integration and optimal bone regeneration [34] [35] [36] . The objective of this study was to implement the multilayered nanostructures approach to equip those already used in the clinic devices with nanocontainers of active compounds capable of improving the rate of bone regeneration: chitosan (CHI), a biocompatible polysaccharide with bone regenerative properties [37, 38] ; and BMP-2, a growth factor known to accelerate ECM production and bone tissue integration [39] . First, we inspected the build-up of our coating with quartz crystal microbalance with dissipation monitoring (QCM-D) and the structure and topography of our nanofibers by scanning electron microscopy (SEM). The potency of the BMP-2-loaded scaffolds with regards to bone regeneration was assessed both in vitro and in vivo.
Methods
n Materials CHI was purchased from Sigma (France) and Protasan up CL 113 was from FMC Biopolymer (Norway). DGL adendri-graft poly-l-lysine was purchased from Colcom (Montpellier, France). In this study, we used the fifth-generation DGL G5 . Human recombinant BMP-2 was purchased from PeproTech (France). Bio-Gide collagen membranes was purchased from Proforma (Geistlich Bio-Gide 30 × 40 mm). n Quartz crystal microbalance with dissipation monitoring QCM-D was operated with a D300 system (Q-Sense, Sweden) using a QAFC302 flow chamber and QSX301 gold-coated quartz crystal sensors. This technique consists of measuring the resonance frequency shifts (∆f ) and the dissipation factor changes (∆D) of the quartz crystal sensor upon material deposition. The LbL build-up was performed by successive injections of polyelectrolyte or protein solutions (500 µl) and rinsing solution (500 µl) through the flow chamber and was monitored in situ. Changes in the resonance frequencies were measured at the third overtone (n = 3) corresponding to the 15-MHz resonance frequency. A shift in ∆f can be associated, in the first approximation, to a variation of the mass adsorbed onto the crystal through the Sauerbrey relationship: 6 nanoarchitectures were builtup onto Bio-Gide scaffolds by the LbL method by alternating immersions during the 15 min in the adequate solutions (300 µl) at the respective concentrations of 500 µg ml -1 for CHI and DGL G5 solutions and 200 ng ml -1 for the BMP-2 solutions in presence of 0.04 M MES and 0.15 M NaCl at pH 5.5. After each deposition step, the membranes were rinsed for 15 min with 0.04 M MES and 0.15 M NaCl at pH 5.5. All membranes were sterilized for 30 min by exposure to UV light (254 nm; 30 W; distance 20 cm), and equilibrated in contact with 1 ml of serum-free medium prior to cell culture. n SEM observation For morphological study, the scaffolds were goldcoated (Edwards Sputter Coater ® , Edwards, Genevilliers, France) and observed with a Philips XL-30 ESEM ® (Polymex, Fuveau, France) scanning electron microscope in conventional mode (high vacuum) with a Thornley-Everhart ® (Polymex) secondary electron detector. n Cell culture Human primary osteoblasts (HOB) were obtained from Cell Applications and cultured in Dulbecco's modified Eagle's medium (D-MEM ® , Life Technologies, Saint Aubin, France) containing 50 U ml -1 penicillin, 50 µg ml -1 streptomycin, 2.5 µg ml -1 amphotericin B and 10% FBS (Life Technologies, Paisley, UK). The cells were incubated at 37°C in a humidified atmosphere of 5% CO 2 . When cells reached subconfluence, they were harvested with trypsin and subcultured. n In vitro cell viability & proliferation Cell viability was determined by trypan blue exclusion. AlamarBlue ® (Serotec, France) was used to assess cellular proliferation. The AlamarBlue test is a nontoxic, water-soluble, colorimetric redox indicator that changes color in response to cell metabolism. In this study, 
× 10
4 human osteoblasts were seeded on top of LbL-coated 14-mm-diameter scaffolds (n = 3) placed on 24-well plates. After 2 days of culture, cells were incubated in 10% AlamarBlue/ DMEM solution in a humidified atmosphere at 37°C and 5% CO 2 . After 4 h, 100 µl of incubation media was transferred to 96 well plates and measured at 590 nm and 630 nm in order to determine the percentage of AlamarBlue reduction. n In vitro analysis of the mineralization using a fluorescent dye Xylenol orange powder (Sigma) was dissolved in distilled water to make the 20 mM stock solution. Xylenol orange was added to medium overnight to a final concentration of 20 µM. Before the microscopic examination, the samples were rinsed with fresh medium without fluorochrome to avoid nonspecific fluorescence. Xylenol orange expresses a red color under the fluorescent microscope (LEICA DM4000 B). n Immunofluorescence Collagen scaffolds with and without BMP-2 were seeded with 2 × 10 4 HOB cells. After 21 days of culture in proliferation medium, cells were fixed with 4% PFA for 1 h, rinsed three times with PBS, permeabilized with 0.1% Triton X-100 for 1 h, then rinsed three times with PBS. Indirect immunostaining was performed after the fixation. The primary antibody used was the rabbit polyclonal antioteopontin (1/600, Abcam, Paris, France) incubated for 20 min for bone detection. The secondary antibody was goat antirabbit conjugated to Alexa Fluor 488 (1/250, Invitrogen Molecular Probes, Eugene, USA) incubated overnight. After three rinses with PBS, cells were mounted on microscope slides using Vectashield (Vector Laboratories, Peterborough, UK) and imaged by a microscope equipped for fluorescence (LEICA DM4000B). n In vitro analysis of the mineralization using Alizarin Red S staining The samples were fixed with a solution of PFA 4% in PBS overnight at 4°C. They were then dehydrated through a series of increasing ethanol concentrations, cleared with toluene and embedded in paraffin wax. Sections were cut at 7 µm using a sledge microtome and mounted on glass slides. After the removal of paraffin wax, sections of the different samples were stained using Alizarin Red S (Sigma Aldrich). Alizarin Red S powder was dissolved in distilled water in a concentration of 2 g per 100 ml. The samples were incubated in the Alizarin Red solution for 20 min and then rinsed with distilled water several times. The sections were then observed under the optical microscope (LEICA DM4000 B). n In vivo implantations In this study, nude mice were implanted on the skull. The mice were anesthetized with isofluorane gas and animals were placed on ventral decubitus on a heating table, with strict aseptic conditions after skin incision, two bony defects (5-mm size of bony defect) were performed using an electric drill with a sterile round bur under irrigation of sterile normal saline before deposition of two samples and sutures with Ethicon 9/0. The skin was closed with sutures and the animal's behavior was observed after waking up. The mice were sacrificed with an intraperitoneal injection of a lethal dose of ketamine and the samples are extracted after 42 days of implantation. For all in vivo studies, male MF1-nu/nu future science group mice (5 weeks old, weight 30 g) were purchased from Harlan (IL, USA) and acclimatized for a minimum of 1 week prior to experimentation. All procedures were performed with prior received ethical approval and carried out in accordance with the regulations laid down for animals. n Histological examination of bone regeneration using Mallory coloration The implants were fixed with BouinHollande solution for 2 days. Then, they were dehydrated through a series of increasing ethanol concentrations, cleared with toluene and embedded in paraffin wax. Sections were cut at 7 µm using a sledge microtome and mounted on glass slides. After the removal of paraffin wax, the sections were stained using Mallory coloration for 2 days.
n Confocal Raman microspectroscopy After 42-day implantation into mouse calvaria, the implants were explanted, rinsed with PBS, fixed with PFA 4% for 24 h at 4°C, then rinsed three times and stored in PBS. Prior to Raman analysis, the implants were briefly rinsed with water and dried under a gentle flow of argon. Raman measurements were carried out in air using a confocal Raman microspectrometer composed of a Raman spectrometer (LabRam HR
placed before the entrance slit were used to reject Raman signal from out-offocus planes. Raman spectra with a good signalto-noise ratio were recorded with an integration time of 60 s for single spectra and 20 s for 2D mappings.
Results & discussion
Recently, we have reported on the effective incorporation of BMP-2 into (DGL G5 /BMP-2) 6 LbL architectures with DGL, a dendrigraft of poly-l-lysine [39] . The mean amount of hydrated BMP-2 growth factor immobilized was approximately 1.53 µg cm -2 . Here, we have used US FDA-approved CHI as polycationic polysaccharide to incorporate the BMP-2 into the nanostructured coatings. CHI is derived from chitin, a poly saccharide found in the exoskeleton of shellfish such as shrimps, lobsters and/or crabs. The effective build-up of (CHI/BMP-2) n LbL architectures onto gold-coated substrates was demonstrated by QCM-D up to six adsorption cycles. It followed a linear growth regimen with deposited mass increments of approximately 1.1 µg cm -2 corresponding to 10 nm in equivalent uniform thickness upon each new deposited CHI/BMP-2 layer pair. The mean amount of hydrated BMP-2 growth factor immobilized was approximately 0.73 µg cm -2 , which is twofold lower than with DGL G5 . This must be due to more efficient interactions of the protein with the dendritic structure of DGL G5 than with the linear structure of CHI. Our ultimate goal is to propose this new implant as a unique active medical device, we have chosen the FDA-approved CHI and not DGL. After SEM analysis of the nanofiber collagen implant before and after the coating, we have preferred to functionalize the implants by (CHI-BMP-2) 6 and not (CHI-BMP-2) 3 , showing more homogeneity of the coating. The aim of this work is to functionalize active collagen membrane by active nanocontainers that are able to increase the speed of bone regeneration. The effective deposition, and nanoscale dimensions, of the bioactive coating onto Bio-Gide collagen membranes (Figure 1) were confirmed by means of SEM. While the native nanofibers displayed a smooth topography (Figure 2A) , (CHI/BMP-2) 6 -treated nanofibers were coated with uniformly distributed 'fish scale'-like nanostructured deposits ( Figure 2B) . Interestingly, this open fish scale-like morpho logy was very different from the compact spheroid morphology of (DGL G5 /BMP-2) 6 deposits obtained both on collagen membranes and on poly-e-caprolactone (PCL) membranes [39] . Distinct morphologies can be explained by the low flexibility/high persistence length (6-12 nm) of CHI chains [40] , limiting the interactions with BMP-2, while the high flexibility/low persistence length (2 nm) of poly-llysine chains of DGL allows optimized interactions with BMP-2 [41] .
In order to explore the capacity of the modified collagen membranes to induce bone formation in vitro, we have first compared the adhesion of human osteoblasts onto native or (CHI/BMP-2) 6 -treated collagen implants. In line with recently published data [42, 43] , morphology changes between cells adhering onto native and LbL-treated collagen scaffolds were likely to be due to the combined modifications of both the surface chemistry and the nanotopography upon the LbL treatment (data not shown).
We then followed the proliferation and cell activity of human osteoblasts for 21 days onto (CHI/BMP-2) 6 -treated collagen implants compared with native implants (Figure 3) . Our results showed similar cell behavior for both the functionalized and not collagen membranes (Figure 3) , reaching a peak value at day 14. Cell activity then significantly decreased between day 14 and day 21 for both types of substrate. This fall down in proliferation and cell activity, at this stage, is certainly due to the osteoblasts undergoing differentiation to produce their own biomineralized ECM. We have also shown that after 21 days of culture, the proliferation decreased dramatically due to the mineralization at this stage (Figure 4) . Therefore, at 42 days we are unable to follow the proliferation. These results show that the functionalization of the collagen implants with (CHI/BMP-2) 6 nanocontainers did not impair the cell activity.
In order to assess the improvement of in vitro bone formation induced by primary osteoblasts in contact with the BMP-2 nanocontainers, we compared the extent of calcium depositions onto the native collagen implant and (CHI/BMP-2) 6 -treated membranes in the presence of primary osteoblasts. In this study, Xylenol orange fluorescence used as staining for the specific calcium depositions clearly indicated more mineralization onto (CHI/BMP-2) 6 -treated collagen scaffolds than onto the native scaffold (Figure 4) . After an intensity average quantification (22.5 ± 2.3 [ Figure 4A ] and 51.2 ± 4.1 [ Figure 4B ]), we have shown an increase of 23% of bone mineralization by using the functionalized implant (CHI/BMP-2) compared with the native implant. We have also analyzed by immunochemistry the capacity of these nanoreservoirs, in the presence of human osteoblasts, to induce in vitro-specific future science group osteopontin expression after 21 days of culture ( Figure 5 ). This result strongly suggests that the entrapment of BMP-2 into fish scale-like CHIbased LbL nanocontainers preserved its accessibility to osteoblast cells, as well as its ability to increase and accelerate the mineralization of the ECM produced by the osteoblasts. For more in vitro analysis, we have also followed by Alizarin Red detection the calcium deposition on the collagen nanofibers after 21 days incubation of human osteoblasts before and after functionalization with (CHI/BMP-2) 6 nanoreservoirs, and shown calcium deposition when functionalized by BMP-2 (orange detection) and no deposition on the native collagen implant (Figure 6 ).
After the in vitro bone induction, we also analyzed the potential of our active implants to induce bone regeneration in vivo. A native collagen implant and a (CHI/BMP-2) 6 -treated implant were implanted into mouse calvaria defects for 42 days. The histological study was then carried out to observe the scaffold colonization by the host cells in the bone defect site, the osseointegration and the new bone mineralization. Mallory coloration was used in order to distinguish between mineralized bone, ECM and nuclear cell (Figure 7) . The results clearly indicate excellent osseointegration of both (CHI/BMP-2) 6 -treated and untreated collagen membranes, with slightly better results for the treated implant (Figure 7B ). Colonization and migration of osteoblasts from the site of implantation within both implants clearly occurred, as shown by the fibrous aspect of the samples filled with native osteoblasts. However, the (CHI/ BMP-2) 6 -treated collagen implant appears to be more cohesive and shows the formation of an ECM undergoing mineralization ( Figure 7B) .
The bone mineralization of a native collagen implant, and a (CHI/BMP-2) 6 -treated collagen implant after 42-day implantation in calvaria was also inspected by confocal Raman microspectroscopy, to detect calcium phosphate (CaP) deposition (Figure 8) . In this study, we have also analyzed, as a control, a treated implant by using a dendrigraft of l-lysine (DGL G5 ) instead of CHI. These implants were also implanted and analyzed in order to test the versatility of the LbL method for embedding BMP-2 onto the collagen proposed new device. The Raman signatures were very similar for all the implanted scaffolds, except for the bands at 430-450 cm -1 (n 2 PO 4 ), which, promisingly, are relative to B-type carbonated hydroxyapatite (PO 4 3-substituted by CO 3 2 ), the major mineral component of bone (Figure 8 ) [44, 45] . 2D mappings of the 962-cm -1 Raman peak intensity of B-type carbonated hydroxyapatite revealed extensive in vivo mineralization over both (CHI/BMP-2) 6 -and (DGL G5 /BMP-2) 6 -treated scaffolds, while no trace of mineralization was found atop the untreated implant after 42 days implantation (Figure 8) . These results support the promising effect of BMP-2-based nanocontainer deposits on the biomineralization of the implants. In line with our previous work with PCL nanofibrous implants [39] , DGL G5 -based nanoreservoirs of BMP-2 was confirmed here to be a versatile and efficient strategy to induce bone formation. CHI-based nano reservoirs of BMP-2 show similar results in terms of biomineralization in vivo, and seem, to us, to be more promising in the short-/mid-term because CHI is an FDA-approved component, while DGL
G5
is not yet. In addition, although DGL G5 was shown to allow higher loading of the nanoreservoirs with BMP-2 than CHI, as seen before, the amount of growth factor immobilized by means of CHI is sufficient to reach the same extent of implant biomineralization. This can be due to the open fish scale-like morphology of CHI-based nanoreservoirs allowing easier degradation, and thus offering better accessibility to BMP-2 to the cells than the compact spheroid morphology of DGL G5 -based nanoreservoirs [39] .
Conclusion
At this stage, our results show that we can functionalize a collagen implant already used in the clinic with nanocontainers of BMP-2 made by CHI (FDA approved), induce bone formation in vitro and in vivo, and accelerate the speed of bone regeneration in vivo. The European and American authorities have already approved the use of BMP-2 for bone regeneration applications. For example, Medtronic offers InductOS™ (Medtronic, Boulogne-Billancourt, France), which is a basic collagen matrix soaked in BMP-2. The efficacy of this kind of combination device is dependent on slow release kinetics for BMPs, which is recognized as the critical, most challenging requirement for combination implants. For efficient bone regeneration, the target cells require a reliable and continuous exposure to growth factors over an extended period of time, until the induction of new bone. However, degradation of BMP-2 occurs rapidly in aqueous solution. With current systems using collagen matrices soaked with the growth factor, this problem is addressed by overdosing, which may induce adverse side effects. The novelty of our approach lies in the nanoimmobilization of BMP-2. The nano structured scaffold is produced by the LbL technology, which allows to be entrapped the growth factor into nanocontainers atop the scaffold fibers. Recently, we have elucidated the mechanism by which cells come in to contact and interact with such nanostructured coating [19, 43] . Encapsulated by polymers, BMP-2 is likely to be protected and stabilized. Once cells come into contact with the deposits, cellular enzymes degrade this polymer coating and BMP-2 becomes available. As cells grow, divide and infiltrate deeper into the porous structure of the membrane, they provoke a slow and progressive release of BMP-2 that, in turn, further stimulates the biomineralization of the ECM. This strategy aims to considerabley enhance therapeutic efficacy and should lead to implants that are capable, at a reduced cost, of more robust and durable bone repair in large defects compared with current less sophisticated approaches.
Future perspective
Over the next decades, new therapeutics based on nanotechnology could offer significant opportunities to revolutionize medicine. On the other hand, if nanomedicine wants to realize its full potential, some major legal and economic obstacles have to be removed. Here, we describe active living collagen implants with highly promising bone regenerative properties. Our nanotechnology approach allows protective encapsulation as a nanoreservoir of growth factor. This strategy may be used as a new design reflection for a future generation of smart implants for regenerative nanomedicine application. Collagen implants equipped with 'fish scale'-like nanoreservoirs for bone regeneration ReseaRch aRticle
Executive summary
We report on active collagen implants equipped by nanocontainers of BMP-2 for regenerative nanomedicine.
The sophisticated strategy described here should enhance the efficacy of therapeutic implants compared with current simplistic approaches soaked with BMP-2. Our nanotechnology approach allows protective encapsulation as a nanoreservoir of growth factor. We believe that we can develop safer and more effective new-based nanomedicines in a cost-effective and efficient manner. This strategy may serve as a design reflection for biologically inspired materials technologies. 
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